Merck Just Raised Its Dividend. These 3 Dow Healthcare Giants Are Paying More

Resumen detallado
Three Dow healthcare stalwarts just handed shareholders a raise, yet each one faces a threat that could slow the next. Which payout has the strongest backing, and where are the cracks hiding for retirees counting on that check?
Households rarely skip insurance premiums or prescriptions when money gets tight, so healthcare blue chips often sit at the core of a retirement income portfolio. UnitedHealth Group (NYSE:UNH), Merck (NYSE:MRK), and Amgen (NASDAQ:AMGN) are three Dow healthcare stocks that raised their payouts this year. Merck's board recently declared a $0.88 quarterly dividend, up from $0.85. What these three offer is dividend growth backed by earnings, cash flow, and decades of payment history, which matters more than headline yield.
UnitedHealth makes money in two ways. Its UnitedHealthcare unit collects premiums from employers, individuals, and government programs and pays members' medical bills, while Optum runs care delivery, pharmacy benefits, and health data services. In the third quarter, UnitedHealthcare brought in $86.33B of revenue, Optum Rx $39.927B, and Optum Health $22.91B.
At $340.08, the stock yields 2.74% based on $9.06 per share in trailing dividends. The annualized forward rate is $9.28 per share. The next $2.32 payment goes out December 15 to holders of record by the December 7 ex-dividend date.
Many successful investors eventually reach the same moment. The saving is done, the portfolio is built, and the question quietly changes from how much can I grow this to how much can I take out? Get that second question wrong and decades of good investing can come apart in a handful of years.
Coverage is wide. Compare the $9.28 forward dividend with management's raised full-year target of at least $20.50 in adjusted EPS, or the trailing diluted EPS of $17.52. Cash generation is even stronger. The company expects operating cash flow of about $24.0B this year while buying back at least $5.0B of stock. The balance sheet holds $28.549B in cash against $104.129B of shareholders' equity. Debt-to-capital stood at 41.7% with a target of about 40% by year-end.
The track record is steady. The quarterly rate went from $0.90 in 2017 and 2018 to $1.08 in 2019, $1.25 in 2020, and then…
Earn…
Inicio del artículo, extracto de Yahoo Finance. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)




